← Leaderboards
Paul Wesley Noble
Yale University
$36,197,130
Attributed
$38,575,037
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,835,387 · 15
By mechanism
P01$25,770,442 · 5
R01$21,122,240 · 6
R35$5,068,279 · 1
T32$4,178,068 · 2
P50$1,696,358 · 1
Top collaborators
- Dianhua Jiang4 shared
- Carol Jiurong Liang4 shared
- Brigid L.M. Hogan1 shared
Most similar at Yale University
Same institution · by research overlap
- Peter Lengyel$1,922,073
- Maurizio Chioccioli$1,723,703
- Daniel Greif$13,277,104
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungFibrosisPulmonary FibrosisCellsLung DiseasesRegulationExtracellular MatrixEpithelial CellsFibroblastsMesenchymalInflammationChronicTissuesLung InjuryProgramsPhenotypeHyaluronanInjuryMolecularInflammatoryEpithelialAnimal ModelLaboratoriesLung Inflammation
Grant awards (103)
Molecular Regulation of Progressive Pulmonary Fibrosis$847,538
R35 · FY2025 · HL · contact PI
ZIP8-dependent Zinc Metabolic Regulation in Alveolar Progenitor Cell Aging and Fibrosis$533,653
R01 · FY2025 · AG
Molecular Regulation of Progressive Pulmonary Fibrosis$830,589
R35 · FY2024 · HL · contact PI
ZIP8-dependent Zinc Metabolic Regulation in Alveolar Progenitor Cell Aging and Fibrosis$544,545
R01 · FY2024 · AG
Molecular Regulation of Progressive Pulmonary Fibrosis$847,538
R35 · FY2023 · HL · contact PI
ZIP8-dependent Zinc Metabolic Regulation in Alveolar Progenitor Cell Aging and Fibrosis$544,545
R01 · FY2023 · AG
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)$2,368,307
P01 · FY2022 · HL · contact PI
Molecular Regulation of Progressive Pulmonary Fibrosis$847,538
R35 · FY2022 · HL · contact PI
ZIP8-dependent Zinc Metabolic Regulation in Alveolar Progenitor Cell Aging and Fibrosis$544,545
R01 · FY2022 · AG
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease$510,000
P01 · FY2022 · HL · contact PI
Administrative Core$125,213
P01 · FY2022 · HL · contact PI
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)$2,368,307
P01 · FY2021 · HL · contact PI
Molecular Regulation of Progressive Pulmonary Fibrosis$847,538
R35 · FY2021 · HL · contact PI
Innate Immune Mechanisms of Non-infectious Lung Inflammation$525,054
R01 · FY2021 · AI · contact PI
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease$510,000
P01 · FY2021 · HL · contact PI
Multidisciplinary Pulmonary Research Training Program$273,500
T32 · FY2021 · HL · contact PI
Administrative Core$125,213
P01 · FY2021 · HL · contact PI
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)$2,368,307
P01 · FY2020 · HL · contact PI
Molecular Regulation of Progressive Pulmonary Fibrosis$847,538
R35 · FY2020 · HL · contact PI
Innate Immune Mechanisms of Non-infectious Lung Inflammation$525,054
R01 · FY2020 · AI · contact PI
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease$510,000
P01 · FY2020 · HL · contact PI
Multidisciplinary Pulmonary Research Training Program$317,112
T32 · FY2020 · HL · contact PI
Administrative Core$125,213
P01 · FY2020 · HL · contact PI
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)$2,368,307
P01 · FY2019 · HL · contact PI
Matrix Regulation of Pulmonary Fibrosis$595,000
R01 · FY2019 · HL · contact PI
Innate Immune Mechanisms of Non-infectious Lung Inflammation$525,054
R01 · FY2019 · AI · contact PI
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease$510,000
P01 · FY2019 · HL · contact PI
Multidisciplinary Pulmonary Research Training Program$305,315
T32 · FY2019 · HL · contact PI
Administrative Core$125,213
P01 · FY2019 · HL · contact PI
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)$2,403,307
P01 · FY2018 · HL · contact PI
Matrix Regulation of Pulmonary Fibrosis$597,333
R01 · FY2018 · HL · contact PI
Targeting beta-arrestins in Pulmonary Fibrosis$535,527
R01 · FY2018 · HL
Innate Immune Mechanisms of Non-infectious Lung Inflammation$525,054
R01 · FY2018 · AI · contact PI
Administrative Core$400,552
P01 · FY2018 · HL · contact PI
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease$400,551
P01 · FY2018 · HL · contact PI
Multidisciplinary Pulmonary Research Training Program$301,332
T32 · FY2018 · HL · contact PI
Targeting beta-arrestins in Pulmonary Fibrosis$535,527
R01 · FY2017 · HL
Innate Immune Mechanisms of Non-infectious Lung Inflammation$525,054
R01 · FY2017 · AI · contact PI
Multidisciplinary Pulmonary Research Training Program$144,048
T32 · FY2017 · HL · contact PI
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease$1,841,679
P01 · FY2016 · HL · contact PI
Targeting beta-arrestins in Pulmonary Fibrosis$535,527
R01 · FY2016 · HL
Hyaluronan in Pulmonary Fibrosis and Asthma$437,987
P01 · FY2016 · HL · contact PI
Administrative Core$213,145
P01 · FY2016 · HL · contact PI
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease$1,849,593
P01 · FY2015 · HL · contact PI
Targeting beta-arrestins in Pulmonary Fibrosis$535,527
R01 · FY2015 · HL
Hyaluronan in Pulmonary Fibrosis and Asthma$443,799
P01 · FY2015 · HL · contact PI
Matrix Regulation of Pulmonary Fibrosis$411,237
R01 · FY2015 · HL · contact PI
Administrative Core$241,816
P01 · FY2015 · HL · contact PI
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease$1,862,337
P01 · FY2014 · HL · contact PI
Hyaluronan in Pulmonary Fibrosis and Asthma$455,696
P01 · FY2014 · HL · contact PI
Matrix Regulation of Pulmonary Fibrosis$409,150
R01 · FY2014 · HL · contact PI
Administrative Core$240,878
P01 · FY2014 · HL · contact PI
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease$1,830,206
P01 · FY2013 · HL · contact PI
Hyaluronan in Pulmonary Fibrosis and Asthma$421,258
P01 · FY2013 · HL · contact PI
Matrix Regulation of Pulmonary Fibrosis$397,460
R01 · FY2013 · HL · contact PI
Regulation of Pulmonary Fibrosis by CXCR3$393,485
R01 · FY2013 · HL · contact PI
Administrative Core$250,467
P01 · FY2013 · HL · contact PI
Hyaluronan in Pulmonary Fibrosis and Asthma$351,878
P01 · FY2012 · HL · contact PI
Innate Immune Mechanisms in Non-infectious Lung Inflammation$293,689
R01 · FY2012 · AI · contact PI
Administrative Core$111,213
P01 · FY2012 · HL · contact PI
Innate Immune Mechanisms in Non-infectious Lung Inflammation$88,550
R01 · FY2012 · AI · contact PI
Interdisciplinary Training Program in Lung Disease$446,418
T32 · FY2011 · HL · contact PI
Matrix Regulation of Pulmonary Fibrosis$392,500
R01 · FY2011 · HL · contact PI
Regulation of Pulmonary Fibrosis by CXCR3$392,500
R01 · FY2011 · HL · contact PI
Innate Immune Mechanisms in Non-infectious Lung Inflammation$382,239
R01 · FY2011 · AI · contact PI
MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASE$453,305
P50 · FY2010 · HL · contact PI
Interdisciplinary Training Program in Lung Disease$437,968
T32 · FY2010 · HL · contact PI
Regulation of Pulmonary Fibrosis by CXCR3$392,500
R01 · FY2010 · HL · contact PI
Innate Immune Mechanisms in Non-infectious Lung Inflammation$386,100
R01 · FY2010 · AI · contact PI
Mechanisms of Macrophage Activation in Lung Inflammation$378,690
R01 · FY2010 · HL · contact PI
Interdisciplinary Training Program in Lung Disease$508,769
T32 · FY2009 · HL · contact PI
MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASE$448,353
P50 · FY2009 · HL · contact PI
Innate Immune Mechanisms in Non-infectious Lung Inflammation$390,000
R01 · FY2009 · AI · contact PI
Mechanisms of Macrophage Activation in Lung Inflammation$378,690
R01 · FY2009 · HL · contact PI
Interdisciplinary Training Program in Lung Disease$456,869
T32 · FY2008 · HL · contact PI
Innate Immune Mechanisms in Non-infectious Lung Inflammation$390,000
R01 · FY2008 · AI · contact PI
Mechanisms of Macrophage Activation in Lung Inflammation$378,690
R01 · FY2008 · HL · contact PI
Regulation of Pulmonary Fibrosis by CXCR3$369,790
R01 · FY2008 · HL · contact PI
MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASE$277,025
P50 · FY2008 · HL · contact PI
Interdisciplinary Training Program in Lung Disease$484,706
T32 · FY2007 · HL · contact PI
Mechanisms of Macrophage Activation in Lung Inflammation$378,690
R01 · FY2007 · HL · contact PI
Regulation of Pulmonary Fibrosis by CXCR3$369,395
R01 · FY2007 · HL · contact PI
MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASE$274,503
P50 · FY2007 · HL · contact PI
Interdisciplinary Training Program in Lung Disease$502,031
T32 · FY2006 · HL · contact PI
Mechanisms of Macrophage Activation in Lung Inflammation$388,958
R01 · FY2006 · HL · contact PI
Survivin Regulation of Pulmonary Fibrosis$379,806
R01 · FY2006 · HL · contact PI
Immune Mechanisms in Non-Infectious Lung Inflammation$379,614
R01 · FY2006 · AI · contact PI
Regulation of Pulmonary Fibrosis by CXCR3$274,680
R01 · FY2006 · HL · contact PI
MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASE$243,172
P50 · FY2006 · HL · contact PI
Regulation of Pulmonary Fibrosis by CXCR3$124,464
R01 · FY2006 · HL · contact PI
Regulation of Pulmonary Fibrosis by CXCR3$408,750
R01 · FY2005 · HL
Survivin Regulation of Pulmonary Fibrosis$408,750
R01 · FY2005 · HL
Immune Mechanisms in Non-Infectious Lung Inflammation$362,500
R01 · FY2005 · AI
Mechanisms of Macrophage Activation in Lung Inflammation$290,000
R01 · FY2005 · HL
Survivin Regulation of Pulmonary Fibrosis$408,750
R01 · FY2004 · HL
Immune Mechanisms in Non-Infectious Lung Inflammation$362,500
R01 · FY2004 · AI
Mechanisms of Macrophage Activation in Lung Inflammation$290,000
R01 · FY2004 · HL
Survivin Regulation of Pulmonary Fibrosis$408,750
R01 · FY2003 · HL
Immune Mechanisms in Non-Infectious Lung Inflammation$362,500
R01 · FY2003 · AI
Mechanisms of Macrophage Activation in Lung Inflammation$290,000
R01 · FY2003 · HL
Immune Mechanisms in Non-Infectious Lung Inflammation$362,500
R01 · FY2002 · AI
Mechanisms of Macrophage Activation in Lung Inflammation$290,000
R01 · FY2002 · HL
MECHANISMS OF MACROPHAGE ACTIVATION IN LUNG INFLAMMATION$229,364
R01 · FY2000 · HL